Founders, directors and officers

analysisCompany filings describe Wojcicki's earlier work as a healthcare analyst at Passport Capital (2004–2006), Andor Capital Management (2001–2002), Ardsley Partners (1999–2000) and Investor AB (1996–1999), and list her as a board member of Zipline and the Kaiser Permanente Bernard J. Tyson School of Medicine, co-founder and board member of the Breakthrough Prize in Life Sciences, a board member of the Foundation for the National Institutes of Health from 2008 to 2016, a director of the blank check company AJAX I from 2020 to 2021 and of Cazoo Group Ltd. until 2022 (an aggregator dates the end of the Cazoo seat to February 27, 2023). Zipline announced in September 2021 that she had joined its board, as carried by a trade publication. A financial-data aggregator lists further boards, mixing current and former seats, and Sidecar Health lists her on its board of advisors, which is not a board of directors. The SEC's record shows AJAX I as a Cayman Islands company with no listed securities. ^{1 2 3 4 5}

analysisThe Anne Wojcicki Foundation, a private grant-making foundation in Los Altos with a 501(c)(3) exemption since February 2015, reports total assets of $593,310,267 for 2024 in its Form 990-PF, as reproduced by a nonprofit-data service, with Anne Wojcicki as unpaid President and Chair and Susan Wojcicki as Treasurer and Secretary. The Troper Wojcicki Foundation of San Francisco, the counterparty of the January 2024 research agreement, reports $339,320,002 of assets, with Susan Wojcicki as its unpaid President until September 2024. ^{6 7 1}

analysisA financial-data aggregator describes Paul Cusenza as chairman and chief executive of Nodal Exchange since 2008 and earlier an executive of Perlegen Sciences, with no position in the holding company. The Human Immunome Project's board page, the organisation's own biography, describes Linda Avey as a founding general partner of Humain Ventures in Austin, a co-founder of Precisely, Inc. and formerly the founding independent board director of Rock Health. ^{8 9}

analysisRoelof Botha joined the 23andMe, Inc. board in 2017 and was at Sequoia Capital from 2003, a Managing Member of Sequoia Capital Operations from 2007; according to a market-data summary, SpaceX's board elected him an independent director and audit committee member effective June 16, 2026 (an aggregator gives June 15). Patrick Chung joined the 23andMe, Inc. board in 2009 and was Managing General Partner of Xfund from 2015 according to the proxy (an aggregator says 2012); in 2019 he signed Xfund 3's Form D. Richard Scheller was 23andMe's chief scientific officer and head of therapeutics from 2015 to 2019 and chairman of R&D of BridgeBio Pharma; GV's website, which still lists him as a 23andMe director, names his other boards, and he was executive vice president of research and early development at Genentech from 2001 to 2014. ^{1 2 3 4 5 6 7}

analysisNeal Mohan joined the 23andMe, Inc. board in 2017 and is chief executive of YouTube; an aggregator lists him as a Starbucks director from 2024. Sandra Hernández, appointed in November 2021, has been president and chief executive of the California Health Care Foundation since 2014; the foundation announced in 2018 that Governor Jerry Brown had appointed her to the board of Covered California. Valerie Montgomery Rice, appointed in June 2021, is the sixth president and dean of Morehouse School of Medicine and the first woman to lead it; her inauguration biography describes her as founder of a women's health research centre at Meharry Medical College, and an insider-filings aggregator shows her as a UnitedHealth Group director. An aggregator lists Peter J. Taylor, the former audit committee chair, as chairman of Southern California Edison and Edison International since 2022. ^{1 8 9 10 11 12}

analysisMark Jensen retired in 2012 from Deloitte & Touche, where he led audit and enterprise risk services in technology and the venture capital services group, and was earlier chief financial officer of Redleaf Group and Managing Partner of Arthur Andersen's Silicon Valley office; Lattice Semiconductor's 2026 proxy says he has been its director since June 2013 and a Wolfspeed director since May 2025, and sat on the Chrome Holding board from October 2024 to December 2025. ^{1 2}

analysisAndre Fernandez was chief financial officer of WeWork from 2022 to 2023 (WeWork filed for Chapter 11 in November 2023, five months after he left), of NCR from 2018 to 2020 and chief executive of CBS Radio from 2015 to 2017, and in 2025 was a director of Cardlytics; an aggregator still shows his Chrome Holding seat as active although the board was dissolved. Jim Frankola was chief financial officer of Cloudera from 2012 to 2021, of Yodlee and earlier of Ariba, and a director of Ansys and Skillsoft; IonQ appointed him to its board in August 2025, and an aggregator ends his Ansys seat on July 16, 2025, the month Ansys deregistered its securities. ^{3 1 4 5 6 7 8 9}

analysisJoseph Selsavage was chief financial and accounting officer from August 2022, interim chief executive from March 2025 and signed the December 4, 2025 Form 8-K as chief executive; he was earlier chief financial officer of Lemonaid Health from 2020 (an aggregator also calls him its chief executive and ends those posts in 2025), of Metromile and of Hotwire.com. Kathy L. Hibbs, General Counsel of 23andMe in a 2019 directory and later Chief Administrative Officer, is described by an insider-filings aggregator as a director of Sophia Genetics. Matthew Kvarda, the chief restructuring officer, is a Managing Director of Alvarez & Marsal, which was paid $1,300 an hour for his service with a $750,000 incentive on a plan or sale; he had been interim chief financial officer of Revlon, TEAM and Jacuzzi Brands. ^{1 2 3 4 5 6}

analysisThomas Walper is a bankruptcy and restructuring lawyer, a partner of Munger, Tolles & Olson until 2025 and earlier head of corporate restructuring at Plainfield Asset Management; his Form 3 shows him as a director from March 23, 2025 with no securities. The State Bar of California lists Thomas Bradley Walper as an active attorney admitted on December 16, 1980, with no disciplinary actions, matched to him by name, practice and the year of his law degree. On July 20, 2026 Getty Images Holdings appointed him a Class I director, and in July 2026 the Plan Administration Trust filed his declaration supporting the states' stipulation. ^{1 7 8 9 10 11}